PT99738A - Processo para a preparacao de compostos de fluor contendo por exemplo um grupo triazolilo - Google Patents

Processo para a preparacao de compostos de fluor contendo por exemplo um grupo triazolilo

Info

Publication number
PT99738A
PT99738A PT99738A PT9973891A PT99738A PT 99738 A PT99738 A PT 99738A PT 99738 A PT99738 A PT 99738A PT 9973891 A PT9973891 A PT 9973891A PT 99738 A PT99738 A PT 99738A
Authority
PT
Portugal
Prior art keywords
compounds containing
triazolyl group
preparing
fluor compounds
preparing fluor
Prior art date
Application number
PT99738A
Other languages
English (en)
Other versions
PT99738B (pt
Inventor
Marc Lang
Jaroslav Stanek
Edmond Differding
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT99738A publication Critical patent/PT99738A/pt
Publication of PT99738B publication Critical patent/PT99738B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
PT99738A 1990-12-12 1991-12-10 Processo para a preparacao de compostos de fluor contendo por exemplo um grupo triazolilo PT99738B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH392390 1990-12-12

Publications (2)

Publication Number Publication Date
PT99738A true PT99738A (pt) 1992-12-31
PT99738B PT99738B (pt) 1999-05-31

Family

ID=4266402

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99738A PT99738B (pt) 1990-12-12 1991-12-10 Processo para a preparacao de compostos de fluor contendo por exemplo um grupo triazolilo

Country Status (18)

Country Link
US (4) US5227393A (pt)
EP (1) EP0490816B1 (pt)
JP (1) JP3133432B2 (pt)
KR (1) KR100214353B1 (pt)
AT (1) ATE155130T1 (pt)
AU (1) AU649499B2 (pt)
CA (1) CA2057338C (pt)
DE (1) DE59108770D1 (pt)
DK (1) DK0490816T3 (pt)
ES (1) ES2104682T3 (pt)
GR (1) GR3024191T3 (pt)
IE (1) IE914312A1 (pt)
IL (1) IL100266A (pt)
NZ (1) NZ240925A (pt)
PH (1) PH30675A (pt)
PT (1) PT99738B (pt)
TW (1) TW210334B (pt)
ZA (1) ZA919752B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224461B (pt) * 1990-09-18 1994-06-01 Ciba Geigy Ag
TW210334B (pt) * 1990-12-12 1993-08-01 Ciba Geigy Ag
WO1994008973A1 (en) * 1992-10-21 1994-04-28 Sankyo Company, Limited Azole compound
US5426196A (en) * 1993-12-22 1995-06-20 Glaxo Inc. Synthesis of diaryl methanes
IT1286866B1 (it) * 1996-10-28 1998-07-17 Menarini Farma Ind Composti furano-eterociclici,loro preparazione ed uso come inibitori di aromatasi
FI20010905A0 (fi) * 2001-05-02 2001-05-02 Vetcare Oy Uusi eläinlääke
GB0914767D0 (en) * 2009-08-24 2009-09-30 Sterix Ltd Compound
CN102884072A (zh) 2010-04-08 2013-01-16 爱默蕾大学 被取代的雄甾-4-烯二酮
PL2753312T3 (pl) 2011-09-08 2017-06-30 Mereo Biopharma 2 Limited Zastosowanie inhibitora aromatazy w leczeniu hipogonadyzmu i powiązanych chorób
ES2886641T3 (es) 2014-08-11 2021-12-20 Angion Biomedica Corp Inhibidores de citocromo P450 y sus usos
CN107531631B (zh) 2014-12-31 2021-09-03 安吉昂生物医药公司 用于治疗疾病的方法和药剂
GB201614179D0 (en) 2016-08-19 2016-10-05 Mereo Biopharma 2 Ltd Dosage regimen for the treatment of endometriosis

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2407305C2 (de) * 1974-02-15 1984-06-28 Bayer Ag, 5090 Leverkusen Triphenyl-1,2,3-triazol-1-yl-methane, Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide
GB1511195A (en) * 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
GB1555417A (en) * 1977-04-19 1979-11-07 Ici America Inc Triazole compositions
ZA84652B (en) * 1983-02-02 1985-09-25 Lilly Co Eli Aromatase inhibiting pyrimidine derivatives
US4762836A (en) * 1983-02-02 1988-08-09 Eli Lilly And Company Aromatase inhibitors
GB8305377D0 (en) * 1983-02-25 1983-03-30 Pfizer Ltd Antifungal agents
DE3572809D1 (de) * 1984-05-23 1989-10-12 Ciba Geigy Ag Microbicidal 1-fluoro-1-azolyl-2,2-diarylethane derivatives
US4764376A (en) * 1984-06-18 1988-08-16 Eli Lilly And Company Method of inhibiting aromatase
US4845227A (en) * 1984-06-18 1989-07-04 Eli Lilly And Company Aromatase inhibitors from azoles
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
US4757076A (en) * 1984-06-18 1988-07-12 Eli Lilly And Company Method of inhibiting aromatase
US5071861A (en) * 1986-03-07 1991-12-10 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5112845A (en) * 1986-03-07 1992-05-12 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
DE3627310A1 (de) * 1986-08-12 1988-02-18 Biotechnolog Forschung Gmbh Pyocyanin-derivate und herstellungsverfahren
JPS63165376A (ja) * 1986-12-27 1988-07-08 Nippon Soda Co Ltd オキサ（チア）ジアゾ−ル誘導体その製造方法及び殺ダニ剤
NZ224714A (en) * 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions
GB8716650D0 (en) * 1987-07-15 1987-08-19 Ici Plc Use of olefinic compounds
GB8716651D0 (en) * 1987-07-15 1987-08-19 Ici Plc 2-propanol derivatives
DE3811574A1 (de) * 1988-03-31 1989-10-19 Schering Ag N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3819903A1 (de) * 1988-06-11 1989-12-21 Basf Ag 1-halogen-1-azolyl-ethan-derivate und diese enthaltende fungizide
GB8818561D0 (en) * 1988-08-04 1988-09-07 Ici Plc Diphenylethane derivatives
EP0408509B1 (de) * 1989-07-14 1996-03-06 Ciba-Geigy Ag Substituierte Benzonitrile
AU7124691A (en) * 1990-02-27 1991-08-29 Ciba-Geigy Ag Benzofurans
TW224461B (pt) * 1990-09-18 1994-06-01 Ciba Geigy Ag
TW210334B (pt) * 1990-12-12 1993-08-01 Ciba Geigy Ag

Also Published As

Publication number Publication date
EP0490816A2 (de) 1992-06-17
CA2057338C (en) 2002-09-17
ZA919752B (en) 1992-08-26
IE914312A1 (en) 1992-06-17
KR920012049A (ko) 1992-07-25
JPH04300866A (ja) 1992-10-23
DK0490816T3 (da) 1997-09-22
ES2104682T3 (es) 1997-10-16
US5376669A (en) 1994-12-27
EP0490816A3 (en) 1992-12-02
AU649499B2 (en) 1994-05-26
IL100266A (en) 1996-05-14
US5637605A (en) 1997-06-10
US5227393A (en) 1993-07-13
CA2057338A1 (en) 1992-06-13
DE59108770D1 (de) 1997-08-14
AU8889991A (en) 1992-07-09
NZ240925A (en) 1995-02-24
KR100214353B1 (ko) 1999-08-02
US5457209A (en) 1995-10-10
PH30675A (en) 1997-09-16
IL100266A0 (en) 1992-09-06
TW210334B (pt) 1993-08-01
JP3133432B2 (ja) 2001-02-05
PT99738B (pt) 1999-05-31
GR3024191T3 (en) 1997-10-31
ATE155130T1 (de) 1997-07-15
EP0490816B1 (de) 1997-07-09

Similar Documents

Publication Publication Date Title
PT90105A (pt) Processo para a prepracao de aril-hidrazonas
PL295030A1 (en) Method of obtaining substituted derivatives of 2-cyclohexan-1-yl amine
BR9303993A (pt) Composto, processo para preparar o mesmo e composição farmacêutica
PT99738A (pt) Processo para a preparacao de compostos de fluor contendo por exemplo um grupo triazolilo
PT94681A (pt) Processo para a preparacao de benzonitrilos substituidos
BR1100379A (pt) Composto, uso de um composto, preparação farmacêutica e processo para preparação de um composto
PT97796A (pt) Processo para a preparacao de piperidinas substituidas
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
PT98976A (pt) Processo para a preparacao de heteroarilmetilbenzenos
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920818

FG3A Patent granted, date of granting

Effective date: 19990222

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20140224